<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR138">
 <label>138.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Smolen</surname>
    <given-names>JS</given-names>
   </name>
   <name>
    <surname>Genovese</surname>
    <given-names>MC</given-names>
   </name>
   <name>
    <surname>Takeuchi</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Hyslop</surname>
    <given-names>DL</given-names>
   </name>
   <name>
    <surname>Macias</surname>
    <given-names>WL</given-names>
   </name>
   <name>
    <surname>Rooney</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Dickson</surname>
    <given-names>CL</given-names>
   </name>
   <name>
    <surname>Riddle Camp</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Cardillo</surname>
    <given-names>TE</given-names>
   </name>
   <name>
    <surname>Ishii</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Winthrop</surname>
    <given-names>KL</given-names>
   </name>
  </person-group>
  <article-title>Safety profile of baricitinib in patients with active rheumatoid arthritis with over 2 years median time in treatment</article-title>
  <source>J Rheumatol</source>
  <year>2019</year>
  <volume>46</volume>
  <fpage>7</fpage>
  <lpage>18</lpage>
  <pub-id pub-id-type="doi">10.3899/jrheum.171361</pub-id>
  <?supplied-pmid 30219772?>
  <pub-id pub-id-type="pmid">30219772</pub-id>
 </element-citation>
</ref>
